DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Otros (Other)
Multicomponent Oxicam–Metformin Salts:Towards a Strategy for Enhancing Solubility and Stability
Comunicación oral presentada en en GE3C 2026: XXXII Simposio del Grupo Especializado de Cristalografía y Crecimiento Cristalino, celebrado en Jaca del 13 al 16 de enero 2026, Close to 85% of the drugs produced in the United States and Europe are administered orally. However, one of the major challenges for their development is their low solubility and permeability[1]. The design of dual drug–
drug pharmaceutical multicomponent materials (PMMs) has emerged as an effective strategy to overcome these limitations while enabling synergistic therapeutic benefits and combination therapy[2]. This approach is
particularly relevant for type 2 diabetes, where metformin (MTF) is the first-line therapy and comorbid conditions frequently require concomitant non-steroidal anti-inflammatory drugs (NSAID) treatment [3,4]. Here, we report
the synthesis and characterization of a new family of Oxicam–MTF salts involving Piroxicam (PRX), Meloxicam (MLX), and Tenoxicam (TNX). The salts were synthesized using mechanochemical and solution-based methods
and characterized by X-ray diffraction, UV-Vis spectroscopy, and thermal analysis. Structural and computational studies revealed the role of supramolecular synthons in directing the salt formation and highlighted the
relationship between molecular packing and physicochemical properties. These new materials enhanced MTF stability and displayed differences in fluorescence behaviour. Importantly, the incorporation of MTF increased the
aqueous solubility of the Oxicams, while moderating the solubility of free MTF. This study provides a framework for designing PMMs with improved stability, solubility, and pharmaceutical performance., This research has been funded by the project GBRMat PID2023-151538NB-I00, supported by MCIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. E.M-H. acknowledges financial support from
Fundación Guatefuturo (Guatemala) through project PBC-2024-18.